[Preprint] NK cell-monocyte crosstalk underlies NK cell activation in severe COVID-19, 2023, Lee et al.

NK cell-monocyte crosstalk underlies NK cell activation in severe COVID-19
Madeline J Lee; Izumi de los Rios Kobara; Trisha R Barnard; Xariana Vales Torres; Nicole H Tobin; Kathie G Ferbas; Anne W J Rimoin; Otto O Yang; Grace M Aldrovandi; Aaron James Wilk; Jennifer Fulcher; Catherine A Blish

NK cells in the peripheral blood of severe COVID-19 patients exhibit a unique profile characterized by activation and dysfunction. Previous studies have identified soluble factors, including type I interferon and TGFβ, that underlie this dysregulation. However, the role of cell-cell interactions in mediating changes in NK cell function during COVID-19 remains unclear.

To address this question, we combined cell-cell communication analysis on existing single-cell RNA sequencing data with in vitro primary cell co-culture experiments to dissect the mechanisms underlying NK cell dysfunction in COVID-19.

We found that NK cells are predicted to interact most strongly with monocytes and that this occurs via both soluble factors and direct interactions. To validate these findings, we performed in vitro co-cultures in which NK cells from healthy donors were incubated with monocytes from COVID-19+ or healthy donors. Co-culture of healthy NK cells with monocytes from COVID-19 patients recapitulated aspects of the NK cell phenotype observed in severe COVID-19, including decreased expression of NKG2D, increased expression of activation markers, and increased proliferation.

When these experiments were performed in a transwell setting, we found that only CD56bright CD16NK cells were activated in the presence of severe COVID-19 patient monocytes. O-link analysis of supernatants from transwell co-cultures revealed that cultures containing severe COVID-19 patient monocytes had significantly elevated levels of proinflammatory cytokines and chemokines as well as TGFβ.

Collectively, these results demonstrate that interactions between NK cells and monocytes in the peripheral blood of COVID-19 patients contribute to NK cell activation and dysfunction in severe COVID-19.


Link | PDF (Preprint: BioRxiv)

 

Any potential treatments?